CVE-2026-104846Seroval: `fromJSON()` Promise thenable assimilation invokes plugin-produced callables (bypass of CVE-2026-59940)
Updated under an hour ago ()
Does this affect you?
It affects lxsmnsyc seroval. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.34%, higher than 26% of scored CVEs.
Do this next
Free account, 1 product
Seroval facilitates JS value stringification, including complex structures beyond JSON.stringify capabilities. From 0.12.0 until 1.6.2, fromJSON deserialization of a fulfilled Promise control node can pass a plugin-produced callable-bearing thenable to a native Promise resolver. ECMAScript thenable assimilation then invokes the callable unexpectedly, allowing attacker-controlled JSON to trigger code in applications using plugin-capable Seroval releases. This path bypasses the Promise resolver type-confusion remediation in version 1.5.3 for CVE-2026-59940 because the unexpected invocation occurs through native Promise settlement after the referenced value is deserialized. This issue is fixed in version 1.6.2.
- CVSS
- 9.8 CRITICAL (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-843
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.34% (percentile 26)
- Assigned by
- GitHub_M
- NVD analysis
- Deferred
- Record last updated
- Oct 5, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
lxsmnsyc seroval lxsmnsyc:seroval (from the name) | from 0.12.0, < 1.6.2 | CNA record |
References
- https://github.com/lxsmnsyc/seroval/security/advisories/GHSA-p6vx-979v-rg4cx-refsource-confirm
- https://github.com/lxsmnsyc/seroval/commit/f1ffcc96d259f9b5b3d71feb262b58240c90e7b7x-refsource-misc
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.